SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-062922
Filing Date
2023-08-03
Accepted
2023-08-03 14:29:18
Documents
15
Period of Report
2023-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182728-8k_bluewater.htm   iXBRL 8-K 40140
2 FORM OF INDUCEMENT PIO ea182728ex4-1_bluewater.htm EX-4.1 112000
3 FORM OF LETTER AGREEMENT ea182728ex10-1_bluewater.htm EX-10.1 17645
4 PRESS RELEASE, DATED AUGUST 3, 2023 ea182728ex99-1_bluewater.htm EX-99.1 13617
  Complete submission text file 0001213900-23-062922.txt   394276

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bwv-20230801.xsd EX-101.SCH 3012
6 XBRL LABEL FILE bwv-20230801_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE bwv-20230801_pre.xml EX-101.PRE 22358
9 EXTRACTED XBRL INSTANCE DOCUMENT ea182728-8k_bluewater_htm.xml XML 3320
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Blue Water Biotech, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 231139359
SIC: 2834 Pharmaceutical Preparations